Repare Therapeutics Inc.

1.19
0.04 (3.48%)
At close: Jan 30, 2025, 3:59 PM

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17
Net Income -93.80M -29.05M -106.91M -53.42M -27.22M -14.28M -7.80M
Depreciation & Amortization 1.95M 1.98M 1.47M 897.00K 605.00K 407.00K 102.00K
Stock-Based Compensation 25.06M 19.69M 12.83M 2.54M 511.00K 306.00K 34.00K
Other Working Capital -57.12M 10.90M 4.64M 42.40M 5.75M -494.00K -491.00K
Other Non-Cash Items -5.19M -3.94M 1.87M 890.00K 1.71M 1.13M 1.43M
Deferred Income Tax n/a 3.62M 149.00K 588.00K -629.00K 306.00K -11.00K
Change in Working Capital -55.18M 8.03M 4.79M 42.42M 6.59M -484.00K 239.00K
Operating Cash Flow -127.16M 322.00K -85.80M -6.08M -18.43M -12.62M -6.01M
Capital Expenditures -1.94M -602.00K -1.69M -2.24M -1.30M -583.00K -1.16M
Acquisitions n/a 175.18M 40.00K n/a n/a n/a n/a
Purchase of Investments -179.02M -256.58M -7.48M -7.53M n/a n/a n/a
Sales Maturities Of Investments 259.00M 81.40M 7.45M n/a n/a n/a n/a
Other Investing Acitivies n/a -175.18M 14.00K -7.53M n/a n/a n/a
Investing Cash Flow 78.04M -175.78M -1.68M -9.76M -1.30M -583.00K -1.16M
Debt Repayment n/a n/a n/a n/a n/a n/a 1.50M
Common Stock Repurchased 689.00K 433.00K n/a n/a n/a n/a n/a
Dividend Paid n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies 842.00K 880.00K 1.27M 15.80M 103.24M n/a 28.96M
Financial Cash Flow 842.00K 880.00K 95.56M 247.84M 103.24M n/a 30.46M
Net Cash Flow -48.25M -174.91M 8.03M 231.39M 84.08M -13.46M 23.30M
Free Cash Flow -129.10M -280.00K -87.49M -8.32M -19.73M -13.20M -7.16M